ZOXON 2 mg. 30 tablets

In patients with prostatic hyperplasia drug use Zoxon significantly improves urination, and accompanying symptoms, especially frequent urination. The beneficial effects on prostatic hyperplasia is explained by the influence of the receptors located in the muscle tissue and the capsule of the prostate gland and in the area of the bladder neck.
Drug use Zoxon causes a decrease in blood pressure as a result of reducing the total vascular resistance (vasodilation). Administration of a single dose is achieved decrease in blood pressure 24 hours after dosing.
The decrease in blood pressure is prolonged as the highest effect was observed 2 to 6 hours after the administration of the medicinal product. Zoxon beneficial effect on the elevated levels of blood lipids by reducing the concentration of total triglycerides and total cholesterol. Therefore, treatment with Zoxon reduces the risk of developing coronary artery disease (atherosclerosis of the vessels of the heart), also reduced the increase in the left ventricle of the heart, inhibits adhesion of platelets and reduces the tendency towards the formation of blood clots. Zoxon does not exhibit adverse effects on the metabolism and can therefore be administered to patients with bronchial asthma, diabetes mellitus, decreased activity of the left ventricle, of patients suffering from gout and in older patsienti.Farmakoterapevtichna grupaUrologichno, antihypertensive agent, a selective blocker postsynaptic alpha 1 - adrenoceptor.


Evidence
Medicinal product is used to treat adult patients.
Medicinal product for the treatment of hypertension. The doctor may prescribe Zoxon in combination with other medicinal products that reduce blood pressure. The medicine may be used in patients with normal as well as high blood pressure, who are suffering from both prostatic hyperplasia.
In patients suffering from hypertension and both prostatic hyperplasia product Zoxon efficiently affects both diseases.
Medicinal product is used for the treatment of dysuria or other events associated with prostatic hyperplasia, especially for treatment of frequent urination.


Contraindications
Zoxon medicinal product should not be used in patients with known hypersensitivity to the active substance doxazosin or similar substances (quinazoline derivatives) and any of the other veshtestva.Nezhelani reaktsiiLekarstveniyat medicinal product is generally well tolerated.
Dizziness (rarely associated with fainting) can be observed during the treatment especially after the first dose or a higher dose.
Other possible events include headache, fatigue, swelling of the limbs, general weakness, drowsiness, nausea, acute inflammation of the nasal mucosa, nose bleeding, weakness or tremors, gastrointestinal disorders (diarrhea, vomiting, abdominal pain), rare allergic reactions (rashes and itching), jaundice, very rarely cases of urinary incontinence and persistent painful erection.
Ask your doctor any possible occurrence of side effects or other unusual reaktsii.Lekarstveni vzaimodeystviyaEfektite of Zoxon and Druitt used medicines may affect each other. You should tell your doctor about all the medicines you use or will use whether on prescription or without prescription. When your doctor prescribes any other medicine, tell him that you already use Zoxon.Pri Zokson concomitant use of other medicines to treat high blood pressure effect is potentiated and the decrease in blood pressure is amplified.


Pregnancy and lactation
The medicinal product is generally not used during pregnancy. Therefore, in the case of pregnancy or planning pregnancy, tell your doctor who will decide on the further use of Zoxon. Breastfeeding is not recommended during treatment.

Effects on ability to drive and use machines
At the beginning of treatment Zokson may adversely affect activities requiring alertness and quick decision making (driving motor sredstva, operate machinery, work in high places, etc.). Therefore these activities should only be carried out with the consent of the doctor.

Dosage and method of administration
Dosage should always be determined by the physician.
In the treatment of prostatic hyperplasia treatment usually starts with this form of Zoxon which contain less amount of active substance.
The initial dose is most often 1 mg (1 tablet i.e. Zokson 1) once daily.
Upon satisfactory effect, the daily dose may be increased to 2 mg (i.e. 1 tablet Zoxon 2) and then 4 mg (i.e. 1 tablet Zokson 4) and then to a maximum recommended dose of 8 mg (m. a. 2 tablets Zokson 4). Commonly employed maintenance dose is 2 to 4 mg (ie 1 tablet Zokson 2 or 1 tablet Zokson 4) once daily.
In hypertension treatment usually starts with one or Zokson Zokson 2.Nachalnata dose is most often 1 mg (ie 1 tablet Zokson 1) once daily. If necessary, the dose may be increased to 2 mg (i.e. 1 tablet Zokson 2) daily. An unsatisfactory effect daily dose can be gradually increased depending on the patient's response to treatment assessed by reaching the desired level of blood pressure. Recommended interval during which the change doses are 1 to 2 weeks.
The most commonly used dose is 2 to 4 mg (1 tablet Zokson 2 or 1 tablet Zokson 4) daily, maximum daily dose is 16 mg.
The tablets are swallowed whole and not chewed with a little water or some sort of liquid.


Overdose
In case of overdose or accidental use by children, consult a doctor.

Warning
Implementation of Zoxon in patients with impaired hepatic function should be undertaken with increased vnimanie.Nyama experience with Zokson in children.


Caution
Keep out of reach of children.
Do not use after the expiry date stated on the packaging.